Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor historically known for its toxic responses to man-made pollutants such as dioxin. More recently, the AhR has emerged as a suppressor of inflammation, oxidative stress and apoptosis from cigarette smoke by mechanisms that may involve the regulation of microRNA. However, little is known about the AhR regulation of miRNA expression in the lung in response to inhaled toxicants. Therefore, we exposed Ahr−/− and Ahr+/− mice to cigarette smoke for 4 weeks and evaluated lung miRNA expression by PCR array. There was a dramatic regulation of lung miRNA by the AhR in the absence of exogenous ligand. In response to cigarette smoke, there were more up-regulated miRNA in Ahr−/− mice compared to Ahr+/− mice, including the cancer-associated miRNA miR-96. There was no significant change in the expression of the AhR regulated proteins HuR and cyclooxygenase-2 (COX-2). There were significant increases in the anti-oxidant gene sulfiredoxin 1 (Srxn1) and FOXO3a- predicted targets of miR-96. Collectively, these data support a prominent role for the AhR in regulating lung miRNA expression. Further studies to elucidate a role for these miRNA may further uncover novel biological function for the AhR in respiratory health and disease.
Similar content being viewed by others
Introduction
The aryl hydrocarbon receptor (AhR) is a member of the basic helix-loop-helix Per-Arnt-Sim (bHLH-PAS) transcription factor family that is well-known to mediate the toxicological responses of environmental contaminants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Other ligands for the AhR include polycyclic aromatic hydrocarbons (PAHs) such as benzo[a]pyrene (B[a]P), a component of ambient air pollution and cigarette smoke. In the absence of ligand, the AhR is found in the cytoplasm complexed with chaperone proteins, including a dimer of heat shock protein 90 (HSP90) and the immunophilin hepatitis B virus X-associated protein 2 (XAP2)1,2,3. After binding ligand, the AhR translocates to the nucleus, dissociates from these chaperones and forms a heterodimer with the AhR nuclear transporter (ARNT). This AhR:ARNT complex then binds to a dioxin responsive element (DRE; also called xenobiotic response element (XRE) or AhR response element (AhRE)) and initiates the transcription of genes that comprise the AhR gene battery, the prototypical of which are the Phase I cytochrome P450 (CYP) enzymes such as CYP1A1.
While prolonged activation of this AhR pathway by dioxin is typically associated with toxic responses (e.g. cleft palate, hepatomegaly), a broad range of biochemical and genetic studies have now demonstrated that the AhR is essential for many biological functions, including liver development, the induction of endotoxin tolerance and resistance to infection4,5,6,7. Our published data show that the AhR is a potent suppressor of inflammation, oxidative stress and apoptosis caused by exposure to cigarette smoke, the leading cause of preventable death worldwide8,9,10,11,12,13. Many of the protective functions of the AhR against the deleterious effects of cigarette smoke occurred by a mechanism that is independent of classic DRE binding. The mechanism by which the AhR suppresses inflammatory and cell death pathways is unclear but we hypothesize that it involves AhR-dependent regulation of microRNA (miRNA), single-stranded, non-coding, 22 nucleotide-long RNA which act posttranscriptionally to inhibit protein expression14,15. More than 1000 miRNA exist in humans, and it is estimated that ≈30% of the human genome is regulated by miRNA16. Mature miRNAs guide the miRNA-induced silencing complex (miRISC) to the 3′ untranslated region of an mRNA strand which the miRNA can bind to with complementarity. If the miRNA binds to the mRNA with close-to-perfect pairing, the miRISC cleaves the mRNA, causing its degradation17. Alternatively, if the miRNA binds the mRNA with less complementarity, the miRISC can inhibit the translation of the transcript; both of these result in inhibition of protein production18. Since the elucidation of the role of the miRNA lin-14 and lin-4 in the developmental timing of C. Elegans, miRNA have been a burgeoning topic of research. While the transcription factor(s) that control miRNA expression in response to smoke are less well-described, we have shown that the AhR controls the basal expression of miR-196a in primary lung fibroblasts12. Whether the AhR exerts control over pulmonary miRNA expression in response to cigarette smoke is not known. Therefore, we utilized a chronic in vivo cigarette smoke exposure model to evaluate the differential regulation of pulmonary miRNA levels in Ahr+/− and Ahr−/− mice. Our data show that the AhR is involved in the selective modulation of miRNA expression by cigarette smoke, and in particular suppressing levels of miR-96, a miRNA strongly implicated in cancer progression. The AhR also suppresses pulmonary inflammation in response to chronic smoke exposure. A predicted target of miR-96 is Forkhead box O3 (FOXO3a), a transcription factor that negatively regulates inflammation and oxidative stress19,20,21. We now show for the first time that the AhR increased the expression of FOXO3a in response to cigarette smoke. When considered as a whole, the suppression of miR-96 may increase expression of FOXO3a and be how the AhR attenuates inflammation in response to cigarette smoke. These data shed light on a novel role for the AhR in the regulation of pulmonary miRNA expression and hint towards endogenous effector functions for the AhR in maintaining respiratory health.
Results
Ahr−/− mice exhibit enhanced pulmonary neutrophilia in response to chronic cigarette smoke exposure that is not due to increased levels of chemotactic cytokines
We have previously published that the AhR suppresses acute and sub-chronic cigarette smoke-induced pulmonary inflammation, including neutrophil influx to the lung10,22. Whether the AhR is capable of suppressing neutrophilia in response to prolonged exposure is not known. To address this, we exposed Ahr+/− and Ahr−/− mice to cigarette smoke daily for 4 weeks. This exposure regime significantly increased total number of BAL cells in the Ahr−/− mice in response to smoke compared to both air-exposed Ahr−/− mice as well as smoke-exposed Ahr+/− mice (Fig. 1A). There was a significant increase in lymphocytes and macrophages in cigarette smoke-exposed mice, but there was no difference between Ahr−/− and Ahr+/− mice (Fig. 1B and C). Exposure of Ahr−/− mice to cigarette smoke however significantly increased the number of lung neutrophils compared to smoke-exposed Ahr+/− mice (Fig. 1D), supporting that the AhR maintains protection in the lung against excessive neutrophilic inflammation.
Neutrophil recruitment to the lung during injury or infection follows a cascade of tethering, rolling, adhesion, crawling, and transmigration, events that are mediated by chemokines and cytokines. Control over the levels of chemotactic cytokines occurs at both the transcriptional and posttranscriptional levels, the latter also being regulated by miRNA. As the AhR suppression of pulmonary neutrophilia in response to chronic smoke exposure may involve regulation at both of these levels, we examined mRNA and protein expression of key cytokines, including CXCL1 (Gro-α/KC) (Fig. 2A and B), CCL20 (macrophage inflammatory protein-3α [MIP-3α]) (Fig. 2C and D), CCL2 (monocyte chemotactic protein-1 [MCP-1]) (Fig. 2E and F) and CXCL2 (macrophage inflammatory protein-2α [MIP-2α]) (Fig. 2G and H). As there was generally less induction of these cytokines in smoke-exposed Ahr−/− mice (Fig. 2), it is unlikely that differential levels of chemotactic cytokines can account for the significant increase in pulmonary neutrophilia in Ahr−/− mice in response to chronic cigarette smoke exposure.
Genetic ablation of the AhR causes dysregulation of basal pulmonary miRNA expression
To better understand how the AhR might offer protection in the lung, we evaluated miRNA expression. miRNA are key regulators of protein expression by governing mRNA stability and/or translation repression. Given that we have shown there is AhR-dependent regulation of miR-196a in lung fibroblasts12, and that the AhR can control mRNA stability of Cox-2 in response to cigarette smoke9, we evaluated whether the presence of the AhR affects pulmonary miRNA levels in response to chronic smoke exposure model using a commercial miRNA array that compares approximately 84 miRNAs. Our cigarette smoke exposure regime is highly relevant to human exposures, as people often smoke for many years/decades22. First we evaluated whether there were any basal differences in pulmonary miRNA in the lung of naïve mice. A number of miRNAs were identified to have over two-fold differences in expression in air-exposed Ahr−/− compared to the Ahr+/− mice. These miRNA included miR-196a, miR-96 and miR-34c (Fig. 3, green circles). These miRNAs represent those that are regulated by the AhR in the absence of exogenous ligand.
Chronic cigarette smoke differentially regulates miRNA levels in an AhR-dependent manner
We next compared whether there was differential regulation of miRNAs after cigarette smoke exposure for 4 weeks. Preliminary analysis revealed that there were more up-regulated miRNA in the lungs of Ahr−/− compared to that of Ahr+/− mice after exposure to smoke (Fig. 4). In contrast, Ahr+/− mice had more miRNAs that were down-regulated by chronic smoke exposure (Fig. 4). Overall, approximately 62 miRNAs exhibited at least a two-fold difference in relative expression after cigarette smoke exposure (Fig. 4). Several of the miRNAs exhibiting a slight increase are those previously associated with cigarette smoke-induced inflammation, including miR-146a23,24 (approximately 2-fold; Fig. 5). The miRNA with the largest fold-change was miR-135b (approximately 71-fold in Ahr+/− mice) (Fig. 5). Therefore, we next selected miR-146a and miR-135b in conjunction with miRNA exhibiting large relative differences between Ahr−/− and Ahr+/− mice; these were miR-96 and miR-34C. We also selected for validation by qRT-PCR miRNA that were not altered by smoke exposure, including miR-196a (data not shown). These analyses revealed that there were no significant change in the expression of miR-34c (Fig. 6A), miR-196a (Fig. 6B) or miR-146a (Fig. 6C) in mice exposed to cigarette smoke for 4 weeks. There was also no significant difference in the relative levels of these three miRNA based on AhR expression, although there was a trend towards decreased miR-34c. Cigarette smoke significantly increased miR-135b in the lungs of both Ahr−/− and Ahr+/− mice- consistent with the PCR array-but there was no significant difference in the level of miR-135b induction between Ahr−/− and Ahr+/− mice (Fig. 6D). However, there was a significant difference in miR-96 expression between Ahr−/− and Ahr+/− mice exposed to cigarette smoke (Fig. 6E). Here, there was an approximately 4-fold increase in miR-96 after smoke exposure only in Ahr−/− mice, but not AhR-expressing mice. When considered together, these data suggest that the AhR differentially controls the expression of miRNA in response to chronic cigarette smoke exposure.
Kinetic profile of miR-96 reveals induction in Ahr−/− mice is associated with chronic- but not acute- cigarette smoke exposure
Next, we wanted to know if the suppression of miR-96 by the AhR was reflective of chronic exposure, or if this regulation also occurred with more acute exposures. Using both our acute (3 days) and sub-chronic cigarette smoke exposure regimes (2 weeks), we have previously shown that AhR deficiency results in a heightened inflammatory response10,22 similar in nature to the one presented here (Figs 1 and 2). Using a qPCR array, we noticed that there was little change in miR-96 in either Ahr−/− and Ahr+/− mice after 2 weeks of cigarette smoke (Fig. 7A). In fact, there were remarkable fewer miRNAs changed at 2 weeks compared with 4 weeks of exposure (compared Figs 5 and 7). Validation of these array results confirmed that there was no significant change in miR-96 (Fig. 7B). There was also no change in miR-96 with 3 days of smoke exposure (Fig. 7C). Finally, we exposed A549 cells deficient in AhR expression (A549-AhRKO)12 to CSE, an in vitro surrogate of acute cigarette smoke exposure. There was also no change in miR-96 after exposure to CSE in either A549 Parent cells (which express the AhR) or A549-AhRKO cells (Fig. 7D). Thus, we conclude that induction of pulmonary miR-96 in Ahr−/− mice is reflective of a chronic cigarette smoke exposure regime.
Mechanism of AhR-dependent regulation of miR-96 does not involve classic AhR activation
Our data (Figs 5 and 6) show that AhR expression is important in suppressing miR-96 in response to chronic smoke exposure, which we predict is independent of classic AhR activation. Cigarette smoke contains AhR ligands- such as B[a]P- that induce this classic pathway (i.e. AhR translocation to the nucleus and the subsequent transcription of the AhR target gene Cyp1a1). We have previously shown that exposure to cigarette smoke for 2 weeks significantly increases pulmonary Cyp1a1 mRNA only in Ahr+/− mice22; now we show that this induction of Cyp1a1 also occurs with chronic smoke exposure (Fig. 8A). When considered with the data in Fig. 6E, it suggests that classic AhR activation does not appreciably control miR-96 induction. Additional evidence to support this comes from experiments whereby we administered the high affinity endogenous AhR ligand FICZ25 to Ahr+/− mice and evaluated pulmonary AhR activity. In these experiments, there was a significant increase in Cyp1a1 mRNA in the lung (Fig. 8B), indicating strong AhR activation in the lung. However, there was no effect on miR-96 expression (Fig. 8C). We conclude that the suppression of miR-96 by the AhR occurs by a mechanism that is independent of classic AhR activation by either endogenous (FICZ) or exogenous (cigarette smoke) ligands.
Pulmonary HuR and COX-2 expression after 4-week cigarette smoke exposure
We have previously shown that the AhR controls the cellular localization of HuR in response to cigarette smoke9. HuR is a ubiquitous RNA-binding protein that is abundantly localized to the nucleus but shuttles between the nucleus and cytoplasm upon stimulation. It is believed that cytoplasmic localization is important for the mRNA-stabilizing effects of HuR, thereby increasing target protein expression, including those involved in inflammation and cancer progression26,27. Bioinformatic analysis (http://www.targetscan.org) indicated that HuR was a putative target of miR-96, leading us to speculate that AhR regulation of miR-96 may influence lung HuR expression. However, western blot analysis revealed that HuR is constitutively expressed in the lung, with no significant difference in total HuR expression between Ahr−/− and Ahr+/− mice exposed to cigarette smoke (Fig. 9A and B). One of the protein targets of both the AhR and HuR is COX-29,28,29. There was a slight trend towards a change in COX-2 expression between cigarette smoke exposed Ahr−/− and Ahr+/− mice (Fig. 9A and C). Therefore, these results do not strongly support that HuR and COX-2 proteins are major targets for miR-96 in the lung.
AhR-dependent regulation of pulmonary sulfiredoxin 1 (Srxn1) and FOXO3a by chronic cigarette smoke exposure
We were the first to show in vitro that the AhR promotes the induction of Srxn1 expression by a mechanism that is independent of DRE binding30. Srxn1 is an endogenous antioxidant that protects against cigarette smoke-induced oxidative stress31. As miR-96 is also predicted to regulate Srxn1, we evaluated the expression of Srxn1 in the lungs of Ahr−/− and Ahr+/− mice exposed to cigarette smoke for 4 weeks. There was a significant increase Srxn1 mRNA levels only in cigarette smoke-exposed Ahr+/− mice (Fig. 10); there was no induction of Srxn1 in Ahr−/− mice. This data support a role for the AhR in controlling Srxn1. Finally, we evaluated the expression of FOXO3a, another predicted target of miR-96, and a transcription factor that controls both inflammation and oxidative stress19,20. Our new data show that there is a significant induction in FOXO3a in the lungs of Ahr+/− mice exposed to cigarette smoke for 4 weeks (Fig. 11). There was no induction in FOXO3a in Ahr−/− mice, where the levels of FOXO3a remained significantly lower. Collectively our data suggest that miR-96 may contribute to non-canonical regulation of both Srxn1 and FOXO3a by the AhR, and one mechanism by which AhR controls excessive inflammation caused by chronic smoke exposure.
Discussion
Although much is known about the toxicological actions of the AhR in response to polycyclic aromatic hydrocarbons (PAHs) or polychlorinated dibenzo-p-dioxins (PCDDs), very little is understood about the physiological role of the AhR. However, we and others have shown that the potential biological function of the AhR extends well-beyond its transcriptional response to man-made toxicants; these studies have implicated the AhR in the regulation of development, immune homeostasis, cell death and inflammation8,12,13,22,30,32,33. Our new data presented herein suggest that the AhR is involved in the regulation of pulmonary miRNA, a group of ncRNA that are now recognized as major regulators of protein expression. Importantly, these data highlight role of the AhR in controlling miRNA levels in its quiescent state (i.e. in the absence of exogenous ligand), with there being a large number of miRNA expressed at lower levels in the lungs of Ahr−/− mice compared to control mice. Many of the miRNA controlled by the AhR are known to be involved in endogenous regulator functions of the AhR- including proliferation and cell death (e.g. miR-137, miR-196a and miR-133b)12,34,35. These data suggest that the AhR is a homeostatic regulator of basal miRNA expression.
The AhR is highly expressed in the lung36, where it can encounter ligands present in cigarette smoke. Cigarette smoking is the foremost preventable cause of mortality worldwide, with an estimated 8–10 million deaths occurring per year by 203037. Moreover, over one-half of all persistent smokers will die from a tobacco-related disorder, 80% of which is attributable to one of three diseases: cardiovascular disease (CVD), lung cancer, and chronic obstructive pulmonary disease (COPD)38,39. Cigarette smoke is a complex mixture, containing nearly 5000 chemicals, including carcinogens, reactive oxygen species and other chemicals, including AhR ligands such as B[a]P. We have shown in vitro and in vivo the AhR activating potential of cigarette smoke9,13,22. Here we show for the first time, that upon exposure to cigarette smoke, there was a dramatic increase in the number of miRNA in the lungs of both Ahr−/− and Ahr+/− mice. However, there were more miRNA upregulated in response to cigarette smoke in Ahr−/− mice, suggesting that the AhR may also function to control miRNA levels and attenuate an over-abundant expression profile in response to inhalational exposures. Many of the miRNAs (e.g. miR-146a, miR-96) are expressed in the human lung, where their altered expression is strongly implicated in the pathogenesis of lung disease24,40,41. We then chose to validate the expression of five miRNA, including miR-196a, a miRNA involved in proliferation and apoptosis and one previously shown by us to be regulated by the AhR in lung fibroblasts12. There was no significant change in the levels of miR-196a in response to cigarette smoke in either Ahr−/− and Ahr+/− mice, consistent with our in vitro experiments where cigarette smoke extract (CSE) also did not increase miR-196a12. This is different compared to our results in the lung (Fig. 6), where the AhR did not appreciably control miR-196a levels. The reason for this difference is not clear, but suggests that there is some cell-specific regulation of miR-196a by the AhR (i.e. in lung fibroblasts but not other pulmonary cell types).
We were also surprised that there was little change in miR-146a expression in response to chronic exposure to cigarette smoke. miR-146a is a potent suppressor of inflammation42,43, including the suppression of cigarette smoke-induced COX-2 in vitro23. As such, miR-146a may play an important role in inflammation-associated diseases such COPD24,44, lung cancer45,46 and CVD47. There is evidence that miR-146a is transiently induced by inflammatory stimuli, including smoke exposure, where there is a rapid rise followed by a return to basal levels with 24 hours or so40,48. Thus, miR-146a may be initially increased by cigarette smoke (i.e. by initial exposure)- followed by a decline- such that a chronic exposure to cigarette smoke fails to sustain increased levels of miR-146a.
We also examined miR-135b expression, which was significantly upregulated by chronic exposure to cigarette smoke, with their being an approximately 20-fold increase in expression. Our data are not the first to report an increase in miR-135b. Recently, Halappanavar and colleagues demonstrated that miR-135b is significantly increased in the lungs of smoke-exposed mice as a mechanism to resolve the inflammatory response49, supporting an anti-inflammatory role for miR-135b. Although our current (Figs 1 and 2) and previous data8,22 show that the AhR is also a potent suppressor of smoke-induced pulmonary inflammation, these data do not support that miR-135b contributes significantly to the ability of the AhR to attenuate inflammation, given that there was no significant difference in miR-135b induction between Ahr−/− and Ahr+/− mice.
Of the five miRNAs from the array we chose to validate, we found that miR-96 expression was regulated by the AhR. Our data show that chronic cigarette smoke increased expression of miR-96 only in Ahr−/− mice, suggesting that the AhR may in fact be acting as a repressor of miR-96 in response to inhaled toxicants. The role of miR-96 in cigarette smoke-induced disease is unknown, and we are the first to report on the induction of miR-96 by cigarette smoke. There is over-expression of miR-96 in chronic lung diseases where cigarette smoke is the primary environmental risk factor, including idiopathic pulmonary fibrosis (IPF) and non-small cell lung cancer (NSCLC)50,51. Therefore, our results on the induction in miR-96 could have implications for these diseases, as miR-96 has been shown to promote progression/invasion, cell proliferation and chemo-resistance in many types of cancers including prostate cancer52, colorectal cancer53 and NSCLC54. Although dioxin is classified as a human carcinogen- acting through the AhR- there is controversy for the role of the AhR in cancer development. In some studies, the AhR acts as a potent tumor suppressor, recently being shown to repress melanoma growth55, liver carcinogenesis56 and inflammation-associated colorectal tumorigenesis57. Genetic variations in AHR are also implicated in lung cancer susceptibility amongst smokers, where such variation may affect AhR protein expression and/or activity58,59,60. miR-96 is also significantly increased in lung cancer50, lending to the possibility that low AhR (due to genetic alteration) could enhance lung cancer susceptibility in smokers through increased expression of miR-96. In support of a role that AhR expression, but not AhR activation, regulates miR-96 is our data that both FICZ (an endogenous high affinity AhR ligand)25 and chronic cigarette smoke exposure increases Cyp1a1 mRNA without altering miR-96 expression. Our findings are similar to reports that B[a]P induction of hepatic mRNA (>400 genes) occurred without changes in miRNA expression61. How the AhR suppresses miR-96 is not known but could be due to AhR-dependent interaction with pathways that normally suppress miR-96 levels, such as the Wnt/β-catenin pathway62.
The biological target(s) for miR-96 in our model has remained elusive. In response to chronic smoke exposure, the AhR maintains its ability to suppress pulmonary neutrophilia- similar to our published studies using acute and sub-exposure regimes10,22. Despite higher neutrophils in smoke-exposed Ahr−/− mice, there was no significant change in the majority of the chemotactic cytokines we evaluated, with the exception of CCL20. However, a bioinformatics search failed to reveal direct inflammation-related mRNA targets for miR-96, including CCL20. During this investigation, Srxn1 was identified as a putative target and our data show that there is less Srxn1 in Ahr−/− mice. Srxn 1 is an anti-oxidant that protects against oxidative stress by restoring the activity of peroxiredoxins. There is a significant decrease in Srxn1 in COPD31, a chronic disorder caused primarily by cigarette smoke, and one whose pathogenesis is strongly associated with an oxidant/anti-oxidant imbalance. Given that we and others have shown that the AhR protects against oxidative stress30,63,64, it may be that Srxn1 regulation by an AhR/miR-96 axis, in part, protects against the development of COPD.
The regulation of Srxn1 by this AhR/miR-96 axis also links with another previously-identified target of miR-96- FOXO3a. FOXO3a is a member of the FOXO subfamily of forkhead-box transcription factors, and is one that suppresses inflammation and oxidative stress. miR-96 upregulation decreases FOXO3a65, and FOXO3a deficiency increases susceptibility to the development of COPD and lung cancer66,67,68. Now, we show that the AhR controls the expression of FOXO3a, whereby expression of FOXO3a is increased only in the lungs of Ahr+/− mice exposed to cigarette smoke for 4 weeks. Given that FOXO3a inhibits NF-κB activity20, a transcription factor that promotes inflammation, lower FOXO3a levels could therefore contribute to the heightened smoke-induced inflammatory response caused by AhR deficiency. Thus, miR-96 upregulation may indirectly promote inflammation in Ahr−/− mice via suppression of FOXO3a, rather than by directly targeting inflammatory genes. We do not anticipate that this AhR-miR-96-FOXO3a axis suppresses pulmonary inflammation from acute smoke exposure, as there was no change in miR-96 expression following acute and sub-chronic exposures in vivo or by utilizing CSE in vitro. While it has been shown that FOXO3a suppresses pulmonary inflammation in response cigarette smoke exposures- including neutrophilia66 - we consider it unlikely that FOXO3a is how the AhR suppress lung inflammation from acute smoke exposure. The lower FOXO3a in Ahr−/− mice may also explain the lack of induction of Srxn1, as oxidative stress causes FOXO3a to translocate to the nucleus and bind to the promoter of target genes, including peroxiredoxin III (PrxIII)69, a component of the PRXIII/Srxn redox system. Additional studies are needed to elucidate the functional significance of increased miR-96 associated with AhR deficiency, and the potential role of this miRNA towards pulmonary disease development. In conclusion, this study establishes that the AhR is important in controlling the expression of pulmonary miRNA in response to chronic cigarette smoke exposure. Further exploration into the miRNAs and targets affected by the AhR is necessary to confirm biological importance of the AhR in these fundamental processes.
Methods
In vivo cigarette smoke exposure
AhR-knockout (AhR−/−; B6.129 Ahrtm1/J) C57BL/6 mice were obtained from Jackson Laboratory (Bar Harbor, ME) and bred in-house. This Ahr−/− mouse strain carries a targeted deletion of exon 2. A breeding scheme of heterozygous Ahr+/− to Ahr−/− mice was used, rendering mice of the Ahr+/− genotype as littermate controls. For cigarette smoke exposures, age-matched (range 10–14 weeks) and gender-matched Ahr−/− and Ahr+/− mice were exposed to cigarette smoke as described22. Briefly, research cigarettes (3R4F; University of Kentucky, Lexington, KY) were smoked according to the Federal Trade Commission protocol (1 puff/minute/cigarette of 2 s duration and 35-ml volume) in a SCIREQ inExpose Exposure System (SCIREQ, Montreal, QC). Mainstream cigarette smoke was diluted with filtered air and directed into the exposure chamber. Control and Ahr−/− mice were exposed to cigarette smoke for 5 days a week for 4 weeks to mimic a chronic exposure scenario. The average TPM was 240 ± 8.2 mg/m3. Acute (3-day) and sub-chronic exposures (2-weeks) were also performed. Immediately after the final exposure, mice were euthanized by exsanguination. All animal procedures were approved by the McGill University Animal Care Committee (Protocol Number: 5933) and were carried out in accordance with the Canadian Council on Animal Care.
Ligand administration in vivo
The AhR agonist 6-formylindolo(3,2-b)carbazole (FICZ) (Enzo Life Sciences Canada, Burlington, Ontario) was dissolved in DMSO and 1 μg mouse administered intraperitoneally (i.p); the lungs harvested 6 hours post-administration.
Tissue Harvest and Bronchoalveolar Lavage (BAL) Collection
Following the last exposure, mice were anesthetized with Avertin (2,2,2-tribromoethanol, 250 mg/kg i.p.; Sigma-Aldrich, St. Louis, MO) and the mice euthanized by exsanguination. The lungs were excised and lavaged twice with 0.5 mL of PBS. After the bronchoalveolar lavage (BAL) fluid was centrifuged, the supernatant collected, the BAL cell pellets resuspended in PBS and the total cell number was determined by counting on a hemocytometer. Differential cell counts (at least 300 cells/sample) were performed after cytospin slide preparation (Thermo Shandon, Pittsburg, PA) and staining with Hema-Gurr Stain (Merck, Darmstadt, Germany). Lung tissue was collected and either frozen immediately in liquid nitrogen and stored at −80 °C for protein/western blot analysis or stored in RNAlater® (Qiagen Inc., Valencia, CA).
Detection of BAL Cytokine Levels
BAL fluid was collected as described above and stored at −80 °C until used. BAL cytokine levels were evaluated using Luminex® technology (Milliplex xMAP, Millipore, Billerica, MA).
Preparation of Cigarette Smoke Extract (CSE)
CSE was generated from research cigarettes (3R4F; Kentucky Tobacco Research Council (Lexington, KT)) as previously described8,13,70. An optical density of 0.65 (320 nm) was considered to represent 100% CSE8,13 and was diluted in serum-free MEM to 2% CSE13,71,72.
Generation and culture of A549-AhRko cells
Generation of A549-AhR knockout (A549-AhRko) cells was accomplished by zinc finger nucleases (ZFNs) as previously described12,73.
miRNA PCR array
RNA was reverse transcribed and amplified using miScript II Reverse Transcription Kit and miScript miRNA PCR Array (Qiagen, Valencia, CA) according to the instructions provided. miRNA profiling for 96 murine miRNA (MAM-102A, Qiagen) was performed on whole lung homogenates or air- and smoke-exposed Ahr+/− to Ahr−/− mice; one representative sample per exposure condition/AhR genotype was randomly chosen on which to perform the array. miRNA expression was normalized to the housekeeping miRNA (Snord85, Snord66 and Snord68) and analyzed as fold-change relative to air-exposed heterozygous mice utilizing the web-based software system for the miRNA PCR array (Qiagen, http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php).
qRT-PCR for validation of miRNA expression
Lung tissue was homogenized in QIAzol Lysis Reagent, RNA purification was performed using the miRNeasy Micro Kit (QIAGEN). Resulting RNA samples were diluted accordingly to 10 ng/uL. miRNA expression was assessed by two-step TaqMan® RT-PCR (Applied Biosystems, Carlsbad, CA) for miR-196, miR-146a, miR-135b, miR-96, miR-34c, and U6 snRNA, a small nuclear RNA (snRNA) used as an internal control for miRNA analysis. miRNA expression was normalized to the U6 snRNA levels.
qRT-PCR
Total RNA was isolated from homogenized lung from Ahr−/− and Ahr+/− mice as described above. cDNA was generated from DNAase-treated RNA using iScript II Reverse Transcription Supermix (Bio-Rad, Mississauga, ON). Quantitative PCR was then performed by addition of 1 μl cDNA and 0.5 μM primers with SsoFastTM EvaGreen® (Bio-Rad). Data acquisition and analysis was performed on a CFX96 TouchTM qPCR Detection System (Bio-Rad). Primers sequences are as previously published22,30. Melt curve analysis revealed the amplification of a single product, indicating specificity of the primer pairs. The fluorescence detection threshold was set above the non-template control background within the linear phases of PCR amplifications and the cycle threshold (Ct) of each reaction was detected. Gene expression was analyzed using the ΔΔCt method and results are presented as fold-change normalized to housekeeping gene (β-actin). Data are expressed as fold-change relative to the average level of air-exposed controls.
Western blot
Total cellular protein from homogenized mouse lungs was prepared using RIPA buffer (Pierce; Thermo Scientific). Protein quantitation was performed with the bicinchoninic acid (BCA) method (Pierce, Rockford, IL). 20 μg of protein were fractionated on a 10% SDS-PAGE gel and electro-blotted onto Immun-blot PVDF membrane (Bio-Rad Laboratories, Hercules, CA). Antibodies against HuR (1:2000; Santa Cruz Biotechnology), COX-2 (1:1000) (Cayman Chemical, Ann Arbor, MI), FOXO3a (1:100) (Cell Signaling) and total Actin (1:50,000; Milipore, Temecula, CA) were used to assess changes in relative expression. Proteins were visualized using HRP-conjugated secondary antibodies (1:10,000) followed by enhanced chemiluminescence (ECL) and imaged using a ChemiDocTM XRS+ System (Bio-Rad).
Statistical Analysis
GraphPad Prism v6.0 was used to perform all statistical analysis. All results are presented as the mean ± SEM. Statistically significant differences were assessed by two-way analysis of variance (ANOVA) on non-normalized values followed by a post-test for more than 2 groups or student’s t-test (groups of 2).
Additional Information
How to cite this article: Rogers, S. et al. Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure. Sci. Rep. 7, 40539; doi: 10.1038/srep40539 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Rowlands, J. C. & Gustafsson, J. A. Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27, 109–134, doi: 10.3109/10408449709021615 (1997).
Furness, S. G., Lees, M. J. & Whitelaw, M. L. The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH/PAS transcription factors. FEBS Lett 581, 3616–3625 (2007).
Nguyen, L. P. & Bradfield, C. A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21, 102–116 (2008).
Sekine, H. et al. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 29, 6391–6400, doi: MCB.00337-0910.1128/MCB.00337-09 (2009).
Di Meglio, P. et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 40, 989–1001, doi: S1074-7613(14)00183-6 10.1016/j.immuni.2014.04.019 (2014).
Bessede, A. et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511, 184–190, doi: nature1332310.1038/nature13323 (2014).
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C. & Bradfield, C. A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93, 6731–6736 (1996).
Baglole, C. J. et al. The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem 283, 28944–28957 (2008).
Zago, M. et al. Aryl Hydrocarbon Receptor-Dependent Retention of Nuclear HuR Suppresses Cigarette Smoke-Induced Cyclooxygenase-2 Expression Independent of DNA-Binding. PLoS One 8, e74953, doi: 10.1371/journal.pone.0074953 PONE-D-13-22273 (2013).
Thatcher, T. H. et al. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol 170, 855–864 (2007).
de Souza, A. R., Zago, M., Eidelman, D. H., Hamid, Q. & Baglole, C. J. Aryl Hydrocarbon Receptor (AhR) Attenuation of Subchronic Cigarette Smoke-induced Pulmonary Neutrophilia is Associated with Retention of Nuclear RelB and Suppression of Intercellular Adhesion Molecule-1 (ICAM-1). Toxicol Sci, doi: kfu06810.1093/toxsci/kfu068 (2014).
Hecht, E. et al. Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation. Toxicol Appl Pharmacol, doi: S0041-008X(14)00315-9 10.1016/j.taap.2014.08.023 (2014).
Rico de Souza, A. et al. Genetic Ablation of the Aryl Hydrocarbon Receptor Causes Cigarette Smoke-induced Mitochondrial Dysfunction and Apoptosis. J Biol Chem 286, 43214–43228, doi: M111.258764 10.1074/jbc.M111.258764 (2011).
Lau, N. C., Lim, L. P., Weinstein, E. G. & Bartel, D. P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858–862, doi: 10.1126/science.1065062 294/5543/858 (2001).
Lee, R. C. & Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862–864, doi: 10.1126/science.1065329 294/5543/862 (2001).
Ross, J. S., Carlson, J. A. & Brock, G. miRNA: the new gene silencer. Am J Clin Pathol 128, 830–836, doi: W766537X146V6127 10.1309/2JK279BU2G743MWJ (2007).
Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840, doi: nature09267 10.1038/nature09267 (2010).
Doench, J. G. & Sharp, P. A. Specificity of microRNA target selection in translational repression. Genes Dev 18, 504–511, doi: 10.1101/gad.11844041184404 (2004).
Li, Z., Zhang, H., Chen, Y., Fan, L. & Fang, J. Forkhead transcription factor FOXO3a protein activates nuclear factor kappaB through B-cell lymphoma/leukemia 10 (BCL10) protein and promotes tumor cell survival in serum deprivation. J Biol Chem 287, 17737–17745, doi: M111.291708 10.1074/jbc.M111.291708 (2012).
Lin, L., Hron, J. D. & Peng, S. L. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203–213, doi: 10.1016/j.immuni.2004.06.016 S1074761304002055 (2004).
Ferber, E. C. et al. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ 19, 968–979, doi: cdd2011179 10.1038/cdd.2011.179 (2012).
de Souza, A. R., Zago, M., Eidelman, D. H., Hamid, Q. & Baglole, C. J. Aryl Hydrocarbon Receptor (AhR) Attenuation of Subchronic Cigarette Smoke-induced Pulmonary Neutrophilia Is Associated with Retention of Nuclear RelB and Suppression of Intercellular Adhesion Molecule-1 (ICAM-1). Toxicol Sci 140, 204–223, doi: 10.1093/toxsci/kfu068 kfu068 (2014).
Zago, M. et al. The NF-kappaB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts. Toxicol Lett 226, 107–116, doi: S0378-4274(14)00031-9 10.1016/j.toxlet.2014.01.020 (2014).
Sato, T. et al. Reduced MiR-146a Increases Prostaglandin E2 in Chronic Obstructive Pulmonary Disease Fibroblasts. Am J Respir Crit Care Med, doi: 201001-0055OC 10.1164/rccm.201001-0055OC (2010).
Wincent, E. et al. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J Biol Chem 284, 2690–2696, doi: M808321200 10.1074/jbc.M808321200 (2009).
Fan, J. et al. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol 186, 2482–2494, doi: jimmunol.0903634 10.4049/jimmunol.0903634 (2011).
Kotta-Loizou, I., Giaginis, C. & Theocharis, S. Clinical significance of HuR expression in human malignancy. Med Oncol 31, 161, doi: 10.1007/s12032-014-0161-y (2014).
Dixon, D. A. et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108, 1657–1665, doi: 10.1172/JCI12973 (2001).
Sengupta, S. et al. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 278, 25227–25233, doi: 10.1074/jbc.M301813200 M301813200 (2003).
Sarill, M. et al. The aryl Hydrocarbon receptor suppresses cigarette-smoke-induced oxidative stress in association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1. Free Radic Biol Med, doi: S0891-5849(15)00521-3 10.1016/j.freeradbiomed.2015.08.007 (2015).
Singh, A. et al. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med 46, 376–386, doi: S0891-5849(08)00613-8 10.1016/j.freeradbiomed.2008.10.026 (2009).
Harstad, E. B., Guite, C. A., Thomae, T. L. & Bradfield, C. A. Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol Pharmacol 69, 1534–1541, doi: mol.105.020107 10.1124/mol.105.020107 (2006).
Esser, C. & Rannug, A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol Rev 67, 259–279, doi: 67/2/259 10.1124/pr.114.009001 (2015).
Li, Z. M., Zhang, H. Y., Wang, Y. X. & Wang, W. B. MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6. J Drug Target 24, 102–110, doi: 10.3109/1061186X.2015.1057149 (2016).
Yao, C. et al. MiRNA-133b promotes the proliferation of human Sertoli cells through targeting GLI3. Oncotarget 7, 2201–2219, doi: 6876 10.18632/oncotarget.6876 (2016).
Hayashi, S. et al. Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15, 801–806 (1994).
Hays, J. T., McFadden, D. D. & Ebbert, J. O. Pharmacologic agents for tobacco dependence treatment: 2011 update. Curr Atheroscler Rep 14, 85–92, doi: 10.1007/s11883-011-0211-2 (2012).
Athyros, V. G., Katsiki, N., Doumas, M., Karagiannis, A. & Mikhailidis, D. P. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin 29, 1263–1274, doi: 10.1185/03007995.2013.827566 (2013).
Makomaski Illing, E. M. & Kaiserman, M. J. Mortality attributable to tobacco use in Canada and its regions, 1998. Can J Public Health 95, 38–44 (2004).
Sheridan, J. A. et al. Decreased expression of the NF-kappaB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression. Respir Res 16, 54, doi: 10.1186/s12931-015-0214-6 10.1186/s12931-015-0214-6 (2015).
Ma, L. et al. An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS One 6, e26502, doi: 10.1371/journal.pone.0026502 PONE-D-11-09088 (2011).
Bhaumik, D. et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1, 402–411 (2009).
Cheng, H. S. et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med 5, 949–966, doi: 10.1002/emmm.201202318 (2013).
Wang, R. et al. Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 10, 463–473, doi: 10.2147/COPD.S74345 copd-10-463 (2015).
Li, Y. L. et al. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2. Oncotarget, doi: 11040 10.18632/oncotarget.11040 (2016).
Wang, R. J., Zheng, Y. H., Wang, P. & Zhang, J. Z. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol 8, 765–771 (2015).
Fish, J. E. & Cybulsky, M. I. ApoE attenuates atherosclerosis via miR-146a. Circ Res 117, 3–6, doi: CIRCRESAHA.115.306733 10.1161/CIRCRESAHA.115.306733 (2015).
Chen, L. J. et al. MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress. Circ Res 116, 1157–1169, doi: CIRCRESAHA.116.305987 10.1161/CIRCRESAHA.116.305987 (2015).
Halappanavar, S. et al. IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation. J Immunol 190, 3679–3686, doi: jimmunol.1202456 10.4049/jimmunol.1202456 (2013).
Zhu, W. et al. Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer 11, 393, doi: 1471-2407-11-393 10.1186/1471-2407-11-393 (2011).
Nho, R. S., Im, J., Ho, Y. Y. & Hergert, P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am J Physiol Lung Cell Mol Physiol 307, L632–642, doi: ajplung.00127.2014 10.1152/ajplung.00127.2014 (2014).
Xu, L. et al. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1. Tumour Biol, doi: 10.1007/s13277-016-5058-2 10.1007/s13277-016-5058-2 (2016).
Rapti, S. M., Kontos, C. K., Papadopoulos, I. N. & Scorilas, A. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Tumour Biol, doi: 10.1007/s13277-016-5023-010.1007/s13277-016-5023-0 (2016).
Wu, L. et al. miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9. Oncol Lett 11, 945–952, doi: 10.3892/ol.2015.4000 OL-0-0-4000 (2016).
Contador-Troca, M. et al. The dioxin receptor has tumor suppressor activity in melanoma growth and metastasis. Carcinogenesis 34, 2683–2693, doi: bgt248 10.1093/carcin/bgt248 (2013).
Fan, Y. et al. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res 70, 212–220, doi: 0008-5472.CAN-09-3090 10.1158/0008-5472.CAN-09-3090 (2010).
Diaz-Diaz, C. J. et al. The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. Ann Surg, doi: 10.1097/SLA.0000000000001874 (2016).
Spink, B. C. et al. Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer. Toxicol Appl Pharmacol 282, 30–41, doi: S0041-008X(14)00386-X 10.1016/j.taap.2014.10.017 (2015).
Kim, J. H. et al. Aryl hydrocarbon receptor gene polymorphisms affect lung cancer risk. Lung Cancer 56, 9–15 (2007).
Chen, D. et al. Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet Genomics 19, 25–34, doi: 10.1097/FPC.0b013e328316d8d8 (2009).
Yauk, C. L., Jackson, K., Malowany, M. & Williams, A. Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. Mutat Res 722, 131–139, doi: S1383-5718(10)00076-8 10.1016/j.mrgentox.2010.02.012 (2011).
Yan, Z. et al. miR-96/HBP1/Wnt/beta-catenin regulatory circuitry promotes glioma growth. FEBS Lett 588, 3038–3046, doi: S0014-5793(14)00476-1 10.1016/j.febslet.2014.06.017 (2014).
Cheng, Y. H., Huang, S. C., Lin, C. J., Cheng, L. C. & Li, L. A. Aryl hydrocarbon receptor protects lung adenocarcinoma cells against cigarette sidestream smoke particulates-induced oxidative stress. Toxicol Appl Pharmacol 259, 293–301, doi: S0041-008X(12)00014-2 10.1016/j.taap.2012.01.005 (2012).
Zhang, S. et al. Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB. Toxicol Appl Pharmacol, doi: S0041-008X(15)00114-3 10.1016/j.taap.2015.03.023 (2015).
Lin, H. et al. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5, e15797, doi: 10.1371/journal.pone.0015797 (2010).
Hwang, J. W. et al. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. J Immunol 187, 987–998, doi: jimmunol.1001861 10.4049/jimmunol.1001861 (2011).
Herzog, C. R., Blake, D. C. Jr., Mikse, O. R., Grigoryeva, L. S. & Gundermann, E. L. FoxO3a gene is a target of deletion in mouse lung adenocarcinoma. Oncol Rep 22, 837–843 (2009).
Mikse, O. R. et al. FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma. Cancer Res 70, 6205–6215, doi: 0008-5472.CAN-09-4008 10.1158/0008-5472.CAN-09-4008 (2010).
Chiribau, C. B. et al. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J Biol Chem 283, 8211–8217, doi: M710610200 10.1074/jbc.M710610200 (2008).
Carp, H. & Janoff, A. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 118, 617–621 (1978).
Baglole, C. J. et al. Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema. Am J Physiol Lung Cell Mol Physiol 291, L19–29 (2006).
Martey, C. A. et al. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 287, L981–991 (2004).
Ahmed, S., Wang, A., Celius, T. & Matthews, J. Zinc finger nuclease-mediated knockout of AHR or ARNT in human breast cancer cells abolishes basal and ligand-dependent regulation of CYP1B1 and differentially affects estrogen receptor alpha transactivation. Toxicol Sci, doi: kft274 10.1093/toxsci/kft274 (2013).
Acknowledgements
This work was supported by a Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF); the Natural Sciences and Engineering Research Council of Canada (NSERC); and the Canadian Institute for Health Research (CIHR). CJB was supported by a salary award from the Fonds de recherche du Quebec-Sante (FRQ-S). Sarah Rogers was supported by a CIHR Health Professional Student Research Award.
Author information
Authors and Affiliations
Contributions
S.R., M.I., N.G., M.Z., A.R.S. and C.J.B. performed experiments. A.G. and J.M. generated the A549-AhRKO cells. S.R., N.G., M.Z. and C.J.B. contributed to the study design, data analysis and interpretation. S.R., A.R.S., J.M. and C.J.B. wrote and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Rogers, S., de Souza, A., Zago, M. et al. Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure. Sci Rep 7, 40539 (2017). https://doi.org/10.1038/srep40539
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep40539
This article is cited by
-
Involvement of miR-30b in kynurenine-mediated lysyl oxidase expression
Journal of Physiology and Biochemistry (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.